THC
15.7–19.2%
CBD
0.6%
Obamacare is a hybrid testing a moderate 15.7 to 19.2% THC, its memorable name far outpacing its documentation.
No effect, terpene, flavor or medical-use data specific to Obamacare has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
19.2% THC
About Obamacare
Obamacare, whatever the story behind its politically charged name, tests in a moderate hybrid range of 15.7 to 19.2 percent THC, respectable without being remarkable. No breeder is confirmed for this listing, and the rest of the profile stays similarly quiet - no flavor notes, no terpene data, no effect list, and nothing on flowering time, height, or yield. That leaves a strain whose most memorable feature by far is its name rather than anything documented about how it tastes, feels, or grows. Names like this tend to spread through informal channels rather than official breeding programs, which might explain the thin paper trail here. For now, what can be said with confidence is limited to a mid-range THC bracket and a name that guarantees at least a memorable conversation, regardless of what growing it out might eventually reveal.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Obamacare
Is Obamacare an Indica, Sativa, or Hybrid?
Obamacare is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Obamacare?
Obamacare: 19.2% THC and 0.6% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.